Thyroid function/antibodies in sudanese women with polycystic ovarian disease
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Objective: To evaluate thyroid function and hormonal profile in women with polycystic ovary syndrome (PCOS). Methods: A case-control study was conducted at Saad Abualila Center, Khartoum, Sudan. The cases were women with confirmed PCOS based on Rotterdam criteria. The controls were infertile women with no evidence of PCOS. The socio-demographic characteristics and medical history were gathered using a questionnaire. Thyroid hormones (thyroid-stimulating hormone, free tri-iodothyronine, and free thyroxine), anti-thyroid peroxidase, and anti-thyroglobulin antibodies were measured. Results: While there were no significant differences in the age and haemoglobin levels of the two studied groups (55 women in each arm), body mass index was significantly higher in women with PCOS. There were no significant differences in the levels of thyroid-stimulating hormone, luteinizing hormone, follicle stimulating hormone, luteinizing hormone/ follicle stimulating hormone, anti-thyroid peroxidase, anti-thyroglobulin antibodies, cholesterol, triglycerides and low-density lipoprotein cholesterol between the cases and the controls. The mean±standard deviation of free tri-iodothyronine (3.50±0.2 vs. 3.38±0.3 pg/mL, P=0.040) and median (interquartile) high-density lipoprotein cholesterol (37.0 [34.0 to 42.0] vs. 35.80 [29.0 to 41.0] mg/dL, P=0.015) were significantly higher in PCOS patients compared with the control group. In linear regression, PCOS (0.151 pg/mL, P=0.023) and anti-thyroid peroxidase levels (-0.078 pg/mL, P=0.031) were significantly associated with free tri-iodothyronine. Conclusion: Free tri-iodothyronine was a significantly higher among PCOS patients compared with the control group.
Abstract
Objective: To evaluate thyroid function and hormonal profile in women with polycystic ovary syndrome (PCOS). Methods: A case-control study was conducted at Saad Abualila Center, Khartoum, Sudan. The cases were women with confirmed PCOS based on Rotterdam criteria. The controls were infertile women with no evidence of PCOS. The socio-demographic characteristics and medical history were gathered using a questionnaire. Thyroid hormones (thyroid-stimulating hormone, free tri-iodothyronine, and free thyroxine), anti-thyroid peroxidase, and anti-thyroglobulin antibodies were measured. Results: While there were no significant differences in the age and haemoglobin levels of the two studied groups (55 women in each arm), body mass index was significantly higher in women with PCOS. There were no significant differences in the levels of thyroid-stimulating hormone, luteinizing hormone, follicle stimulating hormone, luteinizing hormone/ follicle stimulating hormone, anti-thyroid peroxidase, anti-thyroglobulin antibodies, cholesterol, triglycerides and low-density lipoprotein cholesterol between the cases and the controls. The mean±standard deviation of free tri-iodothyronine (3.50±0.2 vs. 3.38±0.3 pg/mL, P=0.040) and median (interquartile) high-density lipoprotein cholesterol (37.0 [34.0 to 42.0] vs. 35.80 [29.0 to 41.0] mg/dL, P=0.015) were significantly higher in PCOS patients compared with the control group. In linear regression, PCOS (0.151 pg/mL, P=0.023) and anti-thyroid peroxidase levels (-0.078 pg/mL, P=0.031) were significantly associated with free tri-iodothyronine. Conclusion: Free tri-iodothyronine was a significantly higher among PCOS patients compared with the control group.
참고문헌 (21)
- Sirmans SM, "Epidemiology, diagnosis, and management of polycystic ovary syndrome", Clin Epidemiol, 6, pp.1~13 (2013)
- Witchel SF, "The diagnosis of polycystic ovary syndrome during adolescence", Horm Res Paediatr (2015)[DOI]
- Rotterdam ESHRE, "ASRM-Sponsored PCOS Consensus Workshop Group", Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome, 2004, pp.81, 19~25
- Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults, "Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)", JAMA, 285, pp.2486~2497 (2001)
- Ramanand SJ, "Clinical characteristics of polycystic ovary syndrome in Indian women", Indian J Endocrinol Metab, 17, pp.138~145 (2013)
- Janssen OE, "High prevalence of autoimmune thyroiditis in patients with polycystic ovary syndrome", Eur J Endocrinol, 150, pp.363~369 (2004)
- Sinha U, "Thyroid disorders in polycystic ovarian syndrome subjects:a tertiary hospital based cross-sectional study from Eastern India", Indian J Endocrinol Metab, 17, pp.304~309 (2013)
- Nisar S, "Association of polycystic ovary syndrome and Graves’ disease: is autoimmunity the link between the two diseases", Indian J Endocrinol Metab, 16, pp.982~986 (2012)
- Jung JH, "A 27-year-old woman diagnosed as polycystic ovary syndrome associated with Graves’ disease", Intern Med, 50, pp.2185~2189 (2011)
- Moran C, "Adrenal androgen excess and body mass index in polycystic ovary syndrome", J Clin Endocrinol Metab (2015)[DOI]
- Elussein EA, "Clinical patterns and major causes of infertility among Sudanese couples", Trop Doct, 38, pp.243~244 (2008)
- Ahmed M, "Maternal age and intracytoplasmic sperm injection outcome in infertile couples at Khartoum", Sudan. F1000Res, 4, pp.1339~ (2015)
- Elhaj ET, "Thyroid function", antibodies in Sudanese patients with preeclampsia, 2015, pp.6, 87~
- Wu X, "Functional states of pituitaryovary, adrenal and thyroid axes in women with polycystic ovarian syndrome", Zhonghua Fu Chan Ke Za Zhi, 33, pp.153~156 (1998)
- Zironi C, "Evaluation of dopaminergic activity of the hypothalamus in patients with polycystic ovarian syndrome", Minerva Ginecol, 43, pp.443~447 (1991)
- Gulekli B, "Endocrinological, ultrasonographic and clinical findings in adolescent and adult polycystic ovary patients: a comparative study", Gynecol Endocrinol, 7, pp.273~277 (1993)
- Tudose TI, "Lactotropic and thyrotropic functions of the hypophysis in polycystic ovary syndrome", Probl Endokrinol (Mosk), 32, pp.3~7 (1986)
- Lin JF, "Exploration of the classification of polycystic ovarian syndrome", Zhonghua Fu Chan Ke Za Zhi, 41, pp.684~688 (2006)
- Lim SS, "The effect of obesity on polycystic ovary syndrome: a systematic review and meta-analysis.", Obes Rev, 14, pp.95~109 (2013)
- Cibula D, "Is insulin resistance an essential component of PCOS? The influence of confounding factors", Hum Reprod, 19, pp.757~759 (2004)
- Preethi BL, "Assessment of insulin resistance in normoglycemic young adults", Fiziol Cheloveka, 37, pp.118~125 (2011)